Gates urges more tools, vaccine to end AIDS

July 23, 2012 by Kerry Sheridan

AIDS cannot be halted through treatment alone, and more prevention tools, in particular a vaccine, are needed to move seriously toward ending it, philanthropist Bill Gates said Monday.

While the tycoon applauded efforts to get more people worldwide on -- and said his foundation funds both research and care -- he noted more is needed to stamp out the .

"No one should think that we have got the tools yet. We will get the tools but only if we stay the course in terms of the scientific ," Gates told the International AIDS Conference in the US capital.

His Bill & Melinda Gates Foundation has committed more than $2.5 billion in HIV grants to organizations around the world, and has also committed more than $1.4 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Gates spoke to the conference, the world's largest gathering of AIDS scientists and advocates, as part of a panel on how to improve efficiency in funding of the three-decade-old disease that has killed 30 million people.

Gates said research toward a is "very exciting" but noted that even if a vaccine were introduced it would take time before the effects would be seen in the larger population.

"If you get a vaccine say in 10 years then the number of people you need to put on treatment is reduced in about 18 years," he said.

"Unfortunately there is this unbelievable lag time that comes out of that."

More than eight million people in low and middle income countries were on antiretroviral treatment in 2011 according to a UNAIDS report released last week, making up about half of those in need worldwide.

But Gates warned that no amount of funding can come up with enough money to treat everyone infected.

"It is clear that even if you take the most efficient way of doing this work -- the number of people who will eventually need to be on treatment, the amount of money we have is not enough to treat those people," he said.

"The world will make a decision how much those lives matter. And we are in a period of incredible uncertainty right now," he added.

"Just the uncertainty alone creates a certain instability."

Gates urged continued involvement by the AIDS community and reiterated the importance for nations and donors to support research, but also expressed support for ongoing treatment initiatives in the meantime.

"Now if somebody could cure -- which unfortunately that's very much a long shot," he said.

"There are people who are working it but... it is not in the cards at least any time soon, that is why this imperative is so dramatic."

Explore further: AIDS charity honors Gates on eve of global conference

Related Stories

AIDS charity honors Gates on eve of global conference

July 22, 2012
Leading AIDS charity amfAR honored Microsoft tycoon Bill Gates on the eve of the International AIDS Conference, for his part in funding an ongoing struggle against the disease.

US donates extra $150 million to battle AIDS

July 23, 2012
(AP) — Science now has the tools to slash the spread of HIV even without a vaccine — and the U.S. is donating an extra $150 million to help poor countries put them in place, the Obama administration told the world's ...

Recommended for you

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.